AP27A - Substituted indoloquinoxalines. - Google Patents

Substituted indoloquinoxalines. Download PDF

Info

Publication number
AP27A
AP27A APAP/P/1987/000055A AP8700055A AP27A AP 27 A AP27 A AP 27A AP 8700055 A AP8700055 A AP 8700055A AP 27 A AP27 A AP 27A
Authority
AP
ARIPO
Prior art keywords
group
lower alkyl
iodine
substituted
adducts
Prior art date
Application number
APAP/P/1987/000055A
Other languages
English (en)
Other versions
AP8700055A0 (en
Inventor
Jan Olof Einar Bergman
Original Assignee
Leif J I Lundblad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of AP8700055A0 publication Critical patent/AP8700055A0/xx
Application filed by Leif J I Lundblad filed Critical Leif J I Lundblad
Application granted granted Critical
Publication of AP27A publication Critical patent/AP27A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/1987/000055A 1986-01-21 1987-01-09 Substituted indoloquinoxalines. AP27A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8600260A SE8600260D0 (sv) 1986-01-21 1986-01-21 Substituerade indolokinoxaliner

Publications (2)

Publication Number Publication Date
AP8700055A0 AP8700055A0 (en) 1986-11-01
AP27A true AP27A (en) 1988-12-02

Family

ID=20363170

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1987/000055A AP27A (en) 1986-01-21 1987-01-09 Substituted indoloquinoxalines.

Country Status (19)

Country Link
US (1) US4990510A (de)
EP (1) EP0238459B1 (de)
JP (1) JPH07107066B2 (de)
KR (1) KR880700801A (de)
AP (1) AP27A (de)
AT (1) ATE74920T1 (de)
AU (1) AU606047B2 (de)
CA (1) CA1303613C (de)
DE (1) DE3778190D1 (de)
DK (1) DK492587D0 (de)
ES (1) ES2037105T3 (de)
FI (1) FI883373A7 (de)
HU (1) HU201937B (de)
IL (1) IL81209A (de)
NO (1) NO873945L (de)
OA (1) OA08744A (de)
RU (1) RU1776259C (de)
SE (1) SE8600260D0 (de)
WO (1) WO1987004436A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600261D0 (sv) * 1986-01-21 1986-01-21 Lundblad Leif Indolokinoxaliner med substituenter i 6-position som innehaller cykliska grupper
KR960701875A (ko) * 1993-04-22 1996-03-28 우에하라 아키라 인돌로[2,3-b] 퀴녹살린 유도체
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
SE504289C2 (sv) * 1994-06-23 1996-12-23 Leif J I Lundblad Användning av vissa indolo-2,3b-kinoxaliner för framställning av ett läkemedel för inhibering av enzymet HIV-integras
SE504862C2 (sv) * 1994-12-27 1997-05-20 Leif J I Lundblad Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
US6465466B1 (en) 1995-12-22 2002-10-15 Leif J. I. Lundblad Uses of indolo-2 [2,3b] -quinoxalines
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
SE9704723D0 (sv) * 1997-12-17 1997-12-17 Leif J I Lundblad Ligands
SE516067C2 (sv) * 2000-02-18 2001-11-12 Lundblad Leif J I Användning av en förening för framställning av ett läkemedel
US6333327B2 (en) * 2000-02-18 2001-12-25 Leif J. I. Lundblad Method for the treatment of Multiple Sclerosis
GB0022922D0 (en) * 2000-09-19 2000-11-01 Chapman Robert E Compounds for use in medicine
SE529777C2 (sv) * 2006-01-23 2007-11-20 Vironova Ab Nya föreningar och användning därav
DE602008001795D1 (de) 2008-04-30 2010-08-26 Univ Duisburg Essen IndolÄ2,3-bÜ-, IndenÄ1,2-bÜ- und IndenÄ2,1-bÜpyridoÄ2,3-fÜ Quinoxalin-3-Carboxylsäuren und Ester, Verfahren zu ihrer Herstellung und ihre Verwendung als Antivirus- und Antitumormittel
EP2489354A1 (de) * 2011-02-18 2012-08-22 Vironova AB Pharmazeutische Formulierung enthaltend B220 zur topischen Behandlung von Herpes
CN105061432B (zh) * 2015-07-16 2017-09-29 河北大学 6H‑吲哚[2,3‑b]喹喔啉衍生物、药物组合物及其制备和应用
WO2022002898A1 (en) 2020-06-29 2022-01-06 Vironova Medical Ab 6h-indolo(2,3-b)quinoxaline derivatives useful in therapy in particular in a virus infection
US20230312578A1 (en) 2020-06-29 2023-10-05 Vironova Medical Ab 6h-indolo[2,3-b]quinoxaline derivatives useful in therapy
CN117865962A (zh) * 2023-12-11 2024-04-12 江南大学 一类新型吲哚二酮及吲哚并喹喔啉类衍生物荧光化合物及其制备方法和用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Vol. 84 (1986) No. 180.1667 Sci Phorm, 1975 (4) p. 249-260 *

Also Published As

Publication number Publication date
NO873945D0 (no) 1987-09-21
JPS63502588A (ja) 1988-09-29
DE3778190D1 (de) 1992-05-21
HUT47937A (en) 1989-04-28
ATE74920T1 (de) 1992-05-15
WO1987004436A1 (en) 1987-07-30
AP8700055A0 (en) 1986-11-01
ES2037105T3 (es) 1993-06-16
OA08744A (en) 1989-03-31
NO873945L (no) 1987-09-21
IL81209A (en) 1991-04-15
DK492587A (da) 1987-09-18
AU6899587A (en) 1987-08-14
FI883373A0 (fi) 1988-07-15
AU606047B2 (en) 1991-01-31
US4990510A (en) 1991-02-05
CA1303613C (en) 1992-06-16
DK492587D0 (da) 1987-09-18
FI883373A7 (fi) 1988-07-15
SE8600260D0 (sv) 1986-01-21
KR880700801A (ko) 1988-04-12
IL81209A0 (en) 1987-08-31
JPH07107066B2 (ja) 1995-11-15
EP0238459B1 (de) 1992-04-15
RU1776259C (ru) 1992-11-15
EP0238459A1 (de) 1987-09-23
HU201937B (en) 1991-01-28

Similar Documents

Publication Publication Date Title
AP27A (en) Substituted indoloquinoxalines.
RU2126007C1 (ru) Производные индолокарбазолимида, смесь их изомеров и их соли, фармацевтическая композиция с активностью, ингибирующей протеинкиназу c или киназу легкой миозиновой цепи или подавляющей иммунные реакции
US5597831A (en) 6-[X-(2-hydroxyethyl) aminoalkyl]-5,11-dioxo-5,6-dihydro-11-H-indeno[1,2-c]isoquinolines and their use as antineoplastic agents
IE66321B1 (en) Immunostimulating guanine derivatives compositions and methods
SU978730A3 (ru) Способ получени этилового эфира 9-фенилгидразоно-6-метил-4-оксо-6,7,8,9-тетрагидро-4н-пиридо/1,2-а/-пиримидин-3-карбоновой кислоты
JPS6225670B2 (de)
IE921770A1 (en) Substituted diaminophthalimides and analogues
US5652239A (en) Pyridazinedione derivatives useful in treatment of neurological disorders
EP0008802B1 (de) Ergolinderivate, ihre Herstellung und diese enthaltende therapeutische Zusammensetzung
JPS6322082A (ja) １―（ヒドロキシスチリル）―５ｈ―２，３―ベンゾジアゼピン誘導体およびその製造方法、並びに前記誘導体を含む薬剤
RU2120939C1 (ru) 6-[x-(2-гидроксиэтил)аминоалкил]-5,11-диоксо-5,6-дигидро-11h-инде- но/1,2-с/изохинолины или их соли с неорганическими и органическими кислотами, способы их получения и фармацевтическая композиция на их основе
KR840000794B1 (ko) 퀴나졸린 유도체의 제조방법
US4088647A (en) Pyrazino (1,2,3-ab)-β-carboline derivatives and salts thereof and method of preparing same
JPH01228965A (ja) 縮合キノリン系化合物及び縮合アクリジン系化合物、それらの製造法ならびにそれらの化合物を有効成分とする抗癌剤
NO801843L (no) Nye kinazolinderivater og farmasoeytiske preparater
US4916124A (en) Indoloquinoxalines with substituents in 6-position containing cyclic groups as antiviral agents
US4482714A (en) Pyrazino[2',3'-3,4]pyrido[1,2-a]indole derivatives
NL8600976A (nl) (-)-1 beta-ethyl-1 alfa-hydroxymethyl-1,2,3,4,6,7,12,12 b alfa-octahydroindool2,3-achinolizine, werkwijze voor de bereiding ervan en farmaceutische preparaten met een dergelijke verbinding erin.
US4515949A (en) [2-(1H-indol-1-yl)ethyl]-2-piperazine and pyrido[1,2-a]indol-9-one as intermediates for pyrazino(2,3-3,4)pyrido(1,2-a) indoles which are useful for treating hypertension in mammals
US4661297A (en) Basic ethers of 7-oxo-7H-benzo(c) fluorene and a process for their production
AU634654B2 (en) Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
US3875161A (en) Imidazo(2,1-b)quinazolin-5(1OH)-ones
JPH01249774A (ja) ５―（置換アミノ）―８―（フエニルまたは置換フエニル）―３Ｈ，６Ｈ―１，４，５ａ，８ａ―テトラアザアセナフチレン―３―オン
JPS58201782A (ja) 新規１，１０−フエナントロリン誘導体、その製造法および組成物
EP0558613A1 (de) Pyridobenzindol-derivate,ihre darstellung und pharmazeutische zusammensetzungen, die sie enthalten